The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells is a paramount challenge with the biopharmaceutical industry. Multiple strategies have been employed to antibody titer, comprising process parameter optimization, cell line development, and the use of perfusion technologies. Fine-tuning culture conditions pla